findmyKOL
Clinical trialNCT04644068Active, not recruitingPhase 1/PHASE2Interventional

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

SponsorAstraZenecaEnrollment702Additional Indications Below for Module 4 and 5Biliary CancerBladder CancerBreast CancerCervical CancerColorectal Cancer+7 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

68 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Research Site

    Heidelberg, Australia

  • Research Site

    Melbourne, Australia

Canada
  • Research Site

    Vancouver, British Columbia, Canada

  • Research Site

    Toronto, Ontario, Canada

  • Research Site

    Montreal, Quebec, Canada

  • Research Site

    Montreal, Quebec, Canada

China
  • Research Site

    Beijing, China

  • Research Site

    Changchun, China

  • Research Site

    Changsha, China

  • Research Site

    Chengdu, China

  • Research Site

    Chongqing, China

  • Research Site

    Guangzhou, China

  • Research Site

    Harbin, China

  • Research Site

    Jining, China

  • Research Site

    Shandong, China

  • Research Site

    Shanghai, China

  • Research Site

    Shanghai, China

  • Research Site

    Taiyuan, China

  • Research Site

    Wuhan, China

  • Research Site

    Xi'an, China

Czechia
  • Research Site

    Brno, Czechia

  • Research Site

    Prague, Czechia

Hungary
  • Research Site

    Budapest, Hungary

  • Research Site

    Budapest, Hungary

  • Research Site

    Budapest, Hungary

Italy
  • Research Site

    Milan, Italy

  • Research Site

    Milan, Italy

  • Research Site

    Modena, Italy

  • Research Site

    Naples, Italy

  • Research Site

    Padova, Italy

  • Research Site

    Roma, Italy

Japan
  • Research Site

    Chūōku, Japan

  • Research Site

    Kōtoku, Japan

Poland
  • Research Site

    Bydgoszcz, Poland

  • Research Site

    Gdansk, Poland

  • Research Site

    Gdynia, Poland

  • Research Site

    Grzepnica, Poland

  • Research Site

    Lodz, Poland

  • Research Site

    Torun, Poland

  • Research Site

    Warsaw, Poland

28 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
12 Nov 2020
Primary completion
28 May 2027
Completion
28 May 2027
Last update posted
19 Feb 2026
Registered enrollment
702
Registry id
NCT04644068

Cross-registrations

EU-CTR / CTIS (EudraCT)2020-002688-77

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.